Search results
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters via AOL· 1 day agoNovavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators...
Evolving With the Virus: Repeat COVID-19 Shots Neutralizing Beyond the Expected
SciTechDaily· 3 days agoDue to the virus’s remarkable capacity for mutation and immune evasion, the World Health...
Researchers develop mRNA vaccine for strain of avian flu | Arkansas Democrat Gazette
Arkansas Democrat-Gazette· 12 hours agoUniversity of Pennsylvania researchers have developed an mRNA vaccine for the H5N1 avian flu drawing...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 3 days agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...
Early signs of rising COVID in California as new FLiRT subvariants dominate
Los Angeles Times· 11 hours agoCalifornia may be headed to an earlier-than-normal start to the summer COVID-19 season, with...
Mayo Clinic must face religious bias claims over COVID vaccine policy, court rules
Reuters· 1 day agoA U.S. appeals court on Friday revived a lawsuit accusing the Mayo Clinic in Minnesota of illegally...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 1 day agoUnlike the COVID-19 pandemic, when the U.S. government subsidized private companies to make the COVID-19 ...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters· 1 day ago, opens new tab will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has started ...
Sarasota hospital board bucks Ladapo's claims against COVID-19 vaccines
WUSF 89.7· 4 days agoSarasota Memorial Health Care System will not endorse Florida Surgeon General Joseph Ladapo's guidance against COVID-19 vaccines on its ...
Why Vaccine Stocks Rallied This Week | The Motley Fool
The Motley Fool· 1 day agoShares of vaccine stocks Moderna (MRNA 1.58%), Novavax (NVAX 2.31%), and BioNTech SE (BNTX -2.07%)...